Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

by Scott, R, Donoghoe, M, Watts, G.F, O'Brien, R, Pardy, C, Taskinen, M.-R, Davis, T.M.E, Colman, P.G, Manning, P, Fulcher, G, Keech, A.C
Published 2020